Psilocybin therapy reduces depression in clinicians after pandemic frontline work

SAN DIEGO — Patients with mantle cell lymphoma (MCL) and undetectable minimal residual disease (uMRD) after induction therapy did not live longer if they underwent

The FDA is clar­i­fy­ing in­stances where gener­ic drug ap­pli­cants can re­quest that the agency re­con­sid­er an ap­pli­ca­tion, ac­cord­ing to an up­dat­ed draft guid­ance pub­lished Wednes­day.

In­tel­lia Ther­a­peu­tics has re­vealed that a sin­gle in­fu­sion of its ex­per­i­men­tal CRISPR ther­a­py, called NT­LA-2002, al­most en­tire­ly elim­i­nat­ed swelling at­tacks in 10 peo­ple with hered­i­tary